Please Sign In

Certis is a precision oncology and translational science company. We bring certainty to lead candidate selection and help secure clear and compelling evidence of drug efficacy. Our science starts with highly characterized, low-passaged tumors—many pretreated with current standard of care. We combine deep experience in orthotopic PDX development, advanced imaging and histology techniques, and Immuno-oncology expertise with a culture of precision and exacting scientific standards. The result: clinically relevant results, and reliable, actionable information for your “go or no-go” development decisions. That’s Certis Oncology Intelligence.